Stock DNA
Pharmaceuticals & Biotechnology
CAD 1,300 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.55
-7.35%
1.57
Revenue and Profits:
Net Sales:
357 Million
(Quarterly Results - Jun 2025)
Net Profit:
17 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
47.78%
0%
47.78%
6 Months
197.18%
0%
197.18%
1 Year
275.71%
0%
275.71%
2 Years
978.38%
0%
978.38%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
WELL Health Technologies Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
95.03%
EBIT Growth (5y)
1.62%
EBIT to Interest (avg)
-0.72
Debt to EBITDA (avg)
3.53
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.71
Tax Ratio
44.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.41%
ROCE (avg)
1.44%
ROE (avg)
0.27%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.56
EV to EBIT
-311.88
EV to EBITDA
22.36
EV to Capital Employed
1.36
EV to Sales
1.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.44%
ROE (Latest)
-7.35%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Sep 2022
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.41%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
356.70
243.10
46.73%
Operating Profit (PBDIT) excl Other Income
54.30
31.40
72.93%
Interest
12.70
9.60
32.29%
Exceptional Items
6.90
112.00
-93.84%
Consolidate Net Profit
17.00
117.00
-85.47%
Operating Profit Margin (Excl OI)
81.00%
58.10%
2.29%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 46.73% vs 42.25% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -85.47% vs 5,950.00% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
919.70
776.10
18.50%
Operating Profit (PBDIT) excl Other Income
52.90
101.90
-48.09%
Interest
36.90
32.30
14.24%
Exceptional Items
82.60
14.60
465.75%
Consolidate Net Profit
29.10
16.60
75.30%
Operating Profit Margin (Excl OI)
-21.10%
53.00%
-7.41%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 18.50% vs 36.37% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 75.30% vs -11.23% in Dec 2023
About WELL Health Technologies Corp. 
WELL Health Technologies Corp.
Pharmaceuticals & Biotechnology
WELL Health Technologies Corp is a Canada-based omni-channel digital health company. The Company is primarily engaged in operating primary healthcare facilities, as well as an electronic medical records (EMR) business. The Company provides software as a service (SaaS) EMR services to doctors across Canada. It operates as a national telehealth service and is a provider of digital health, billing and cybersecurity related technology solutions. The Company owns and operates over 20 medical clinics and provides digital EMR software and services to over 2,000 medical clinics across Canada. Its clinics offers a range of services such as walk in appointments, family medicine, sleep apnea facilities, Botox treatments, and women’s clinics. It operates clinics across various cities, including Surrey, Vancouver, North Vancouver, Richmond and Coquitlam. The Company is also engaged in the business of providing secure clinic management, telehealth and practice management software related services.
Company Coordinates 
Company Details
Suite 200, 322 Water Street , VANCOUVER BC : V6B 1B6
Registrar Details






